Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002097334-25-000002
Filing Date
2025-11-19
Accepted
2025-11-19 14:02:39
Documents
1
Period of Report
2025-11-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1429
  Complete submission text file 0002097334-25-000002.txt   2984
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Issuer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 649 3RD STREET EAST UNIT 212 NORTH VANCOUVER BC British Columbia, Canada V7L1G6
Business Address
Lee Arphing (Reporting) CIK: 0002097334 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40501 | Film No.: 251498198